Financhill
Buy
64

CLB Quote, Financials, Valuation and Earnings

Last price:
$16.55
Seasonality move :
5.95%
Day range:
$16.47 - $16.93
52-week range:
$9.72 - $20.82
Dividend yield:
0.24%
P/E ratio:
24.50x
P/S ratio:
1.52x
P/B ratio:
2.85x
Volume:
407.4K
Avg. volume:
424.8K
1-year change:
-1.54%
Market cap:
$774.3M
Revenue:
$523.8M
EPS (TTM):
$0.68

Earnings Data

Next earnings date for CLB
Jan 28
2026
Most recent earnings per share
$0.30
Beat by $0.11
(Oct 22/2025)
Consensus Estimate
$0.19
(Oct 22/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CLB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/28/2026 Q4 $130.4M -- -- $0.19 --
10/22/2025 Q3 $131.3M $134.5M $0.30 $0.19 $0.11
07/23/2025 Q2 $128.7M $130.2M $0.22 $0.18 $0.04
04/23/2025 Q1 $124.8M $123.6M -$0.00 $0.15 -$0.15
01/29/2025 Q4 $133.3M $129.2M $0.16 $0.22 -$0.07
10/23/2024 Q3 $134M $134.4M $0.25 $0.23 $0.01
07/24/2024 Q2 $132.8M $130.6M $0.19 $0.22 -$0.03
04/24/2024 Q1 $124.5M $129.6M $0.07 $0.15 -$0.09
01/31/2024 Q4 $127.5M $128.2M $0.14 $0.19 -$0.05
11/01/2023 Q3 -- $125.3M $0.19 -- --
07/26/2023 Q2 -- $127.9M $0.48 -- --
04/26/2023 Q1 -- $128.4M $0.05 -- --
02/01/2023 Q4 -- $127.6M $0.14 -- --
10/26/2022 Q3 -- $126M $0.16 -- --
07/27/2022 Q2 -- $120.9M $0.15 -- --
04/27/2022 Q1 -- $115.3M -$0.04 -- --
02/02/2022 Q4 -- $125.1M $0.06 -- --
10/27/2021 Q3 -- $118M $0.02 -- --
07/28/2021 Q2 -- $118.7M $0.25 -- --
04/22/2021 Q1 -- $108.4M $0.18 -- --
01/27/2021 Q4 -- $113.7M $0.30 -- --
10/21/2020 Q3 -- $105.4M $0.07 -- --
07/22/2020 Q2 -- $115.7M -$0.13 -- --
04/22/2020 Q1 -- $152.4M -$2.44 -- --
01/29/2020 Q4 -- $156.8M $0.23 -- --
10/23/2019 Q3 -- $173.2M $0.35 -- --
07/24/2019 Q2 -- $169M $0.42 -- --
04/24/2019 Q1 -- $169.2M $0.91 -- --
01/30/2019 Q4 -- $173.2M $0.20 -- --
10/24/2018 Q3 -- $182.1M $0.50 -- --
07/25/2018 Q2 -- $175.5M $0.56 -- --
04/25/2018 Q1 -- $170M $0.53 -- --
01/31/2018 Q4 -- $170.1M $0.49 -- --
10/23/2017 Q3 -- $162.9M $0.48 -- --
07/25/2017 Q2 -- $158.2M $0.51 -- --
04/20/2017 Q1 -- $156.6M $0.40 -- --
01/26/2017 Q4 -- $149.5M $0.35 -- --
10/20/2016 Q3 -- $143.5M $0.38 -- --
07/21/2016 Q2 -- $148.1M $0.38 -- --
04/20/2016 Q1 -- $153.6M $0.35 -- --
01/27/2016 Q4 -- $182.7M $0.36 -- --

Core Laboratories Inc. Earnings Questions

  • How Much did Core Laboratories Inc. Generate in Revenue Last Quarter?

    Core Laboratories Inc. reported $134.5M worth of top line sales in its most recent quarter.

  • Did Core Laboratories Inc. Beat Earnings Last Quarter?

    Core Laboratories Inc. announced earnings per share of $0.30 which represents a beat of analyst forecast a $0.19 per share.

  • Is Core Laboratories Inc. Profitable?

    Core Laboratories Inc. reported $26M that represents $0.55 per share over the last quarter.

  • What is the Analyst Consensus for Core Laboratories Inc. EPS Next Year?

    Core Laboratories Inc.'s earnings are forecast to grow from $0.66 per share to $0.83 per share next year representing an increase of 11.62%.

  • When is Core Laboratories Inc.'s Earnings Date?

    Core Laboratories Inc.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock